| Primary |
| Mycosis Fungoides |
43.2% |
| T-cell Lymphoma |
15.3% |
| Multiple Myeloma |
4.5% |
| Prophylaxis |
4.0% |
| Lung Neoplasm Malignant |
3.1% |
| Myelodysplastic Syndrome |
3.1% |
| Non-small Cell Lung Cancer |
3.1% |
| Breast Cancer Metastatic |
2.6% |
| Plasma Cell Myeloma |
2.6% |
| Acute Myeloid Leukaemia |
2.1% |
| Hypertension |
2.1% |
| Metastases To Central Nervous System |
2.1% |
| Glioblastoma Multiforme |
1.9% |
| Product Used For Unknown Indication |
1.9% |
| Pruritus |
1.7% |
| Diabetes Mellitus |
1.4% |
| Eosinophilia |
1.4% |
| Gastric Cancer |
1.4% |
| Non-hodgkin's Lymphoma |
1.4% |
| Breast Cancer |
1.2% |
|
| Death |
12.6% |
| Weight Decreased |
11.9% |
| Vomiting |
8.8% |
| Renal Failure |
8.2% |
| Mycosis Fungoides |
7.5% |
| Thrombocytopenia |
5.7% |
| Underdose |
5.7% |
| Drug Ineffective |
4.4% |
| Blood Creatinine Increased |
3.8% |
| Platelet Count Decreased |
3.8% |
| Sepsis |
3.8% |
| Drug Level Increased |
3.1% |
| Syncope |
3.1% |
| Disease Progression |
2.5% |
| Fatigue |
2.5% |
| Myocardial Infarction |
2.5% |
| Nausea |
2.5% |
| Neutropenia |
2.5% |
| Pulmonary Embolism |
2.5% |
| T-cell Lymphoma Recurrent |
2.5% |
|
| Secondary |
| Mycosis Fungoides |
31.7% |
| Acute Myeloid Leukaemia |
13.8% |
| Prophylaxis |
7.2% |
| Product Used For Unknown Indication |
6.9% |
| T-cell Lymphoma |
6.6% |
| Constipation |
4.5% |
| Non-hodgkin's Lymphoma |
4.5% |
| Diabetes Mellitus |
3.4% |
| Peripheral T-cell Lymphoma Unspecified |
3.1% |
| T-cell Lymphoma Stage Iv |
3.1% |
| Multiple Myeloma |
2.4% |
| Pneumonia |
2.1% |
| Brain Stem Glioma |
1.7% |
| Cardiac Failure |
1.4% |
| Dry Skin |
1.4% |
| Ileus |
1.4% |
| Mycosis Fungoides Refractory |
1.4% |
| Pruritus |
1.4% |
| Acute Myeloid Leukemia |
1.0% |
| Drug Use For Unknown Indication |
1.0% |
|
| Respiratory Failure |
17.6% |
| Weight Decreased |
12.0% |
| Off Label Use |
7.4% |
| Hypercreatinaemia |
5.6% |
| Sepsis |
5.6% |
| Vomiting |
5.6% |
| Non-hodgkin's Lymphoma |
4.6% |
| Thrombocytopenia |
4.6% |
| Abdominal Pain |
3.7% |
| Death |
3.7% |
| Pyrexia |
3.7% |
| Renal Failure |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Altered State Of Consciousness |
2.8% |
| Constipation |
2.8% |
| Febrile Neutropenia |
2.8% |
| Hypercalcaemia |
2.8% |
| Myocardial Infarction |
2.8% |
| Platelet Count Decreased |
2.8% |
| Arrhythmia |
1.9% |
|
| Concomitant |
| Eczema |
22.9% |
| Multiple Myeloma |
14.3% |
| Brain Neoplasm |
11.4% |
| Sarcoma |
11.4% |
| Nuclear Magnetic Resonance Imaging |
8.6% |
| Breast Cancer Metastatic |
5.7% |
| Erythema |
5.7% |
| Oedema Peripheral |
5.7% |
| Plasma Cell Myeloma |
5.7% |
| Multiple Sclerosis |
2.9% |
| Off Label Use |
2.9% |
| Renal Cancer |
2.9% |
|
| Weight Decreased |
42.1% |
| Brain Neoplasm |
10.5% |
| Skin Tightness |
10.5% |
| Deep Vein Thrombosis |
5.3% |
| Dizziness |
5.3% |
| Malaise |
5.3% |
| Prostate Cancer Metastatic |
5.3% |
| Sensation Of Heaviness |
5.3% |
| Throat Irritation |
5.3% |
| Urinary Tract Infection |
5.3% |
|
| Interacting |
| Product Used For Unknown Indication |
50.0% |
| Pain |
25.0% |
| Mycosis Fungoides |
12.5% |
| Sleep Disorder |
12.5% |
|
| Drug Interaction |
50.0% |
| Torsade De Pointes |
50.0% |
|
